scholarly article | Q13442814 |
P2093 | author name string | Søren Nielsen | |
Reuven Reich | |||
Philip Lazarovici | |||
Ben Davidson | |||
Vivi Ann Flørenes | |||
Björn Risberg | |||
Bilal Sert | |||
Carlos Bedrossian | |||
P2860 | cites work | Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor | Q22010543 |
P433 | issue | 2 | |
P304 | page(s) | 159-165 | |
P577 | publication date | 2004-05-01 | |
P1433 | published in | Lung Cancer | Q641464 |
P1476 | title | Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma | |
P478 | volume | 44 |
Q43281514 | AMP-activated protein kinase supports the NGF-induced viability of human HeLa cells to glucose starvation |
Q37471658 | Cell survival and apoptosis-related molecules in cancer cells in effusions: a comprehensive review |
Q41164101 | Dentin and dental pulp regeneration by the patient's endogenous cells |
Q43078765 | Diagnostic value of neurotrophin expression in malignant pleural effusions |
Q38029833 | Effects of growth factors on dental stem/progenitor cells |
Q54613468 | Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma. |
Q37281015 | Expression of cancer-associated molecules in malignant mesothelioma |
Q37449036 | Future developments in the management of malignant pleural mesothelioma |
Q54683520 | Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma. |
Q57713501 | Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma |
Q34097257 | Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area. |
Q79580992 | Kallikrein 4 is expressed in malignant mesothelioma--further evidence for the histogenetic link between mesothelial and epithelial cells |
Q35903683 | Malignant effusions: from diagnosis to biology |
Q33953901 | Mechanism of cancer pain |
Q81649991 | Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells |
Q48278925 | Neurotrophin system activation in pleural effusions. |
Q37360580 | New diagnostic and molecular characteristics of malignant mesothelioma |
Q37813173 | The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma |
Search more.